» Authors » Fatih Ozaltin

Fatih Ozaltin

Explore the profile of Fatih Ozaltin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 159
Citations 3173
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sukur E, Kurt-Sukur E, Timucin E, Bastug T, Ozaltin F
Clin Genet . 2025 Feb; PMID: 39949197
Steroid-resistant nephrotic syndrome (SRNS) is a severe kidney disorder linked to over 60 genes, including NUP85, which plays a key role in nuclear pore function and glomerulogenesis. We identified a...
2.
Hengel F, Dehde S, Yilmaz A, Bayazit A, Ozaltin F, Paripovic D, et al.
Kidney Int . 2025 Feb; PMID: 39922375
Objective: Autoantibodies against the podocyte protein nephrin were recently identified in a pediatric cohort primarily comprising steroid-sensitive (SSNS) and steroid-dependent (SDNS) nephrotic syndrome (NS). However, their prevalence across all NS...
3.
Tastemel Ozturk T, Gulhan B, Gumus E, Hizarcioglu-Gulsen H, Kurt-Sukur E, Bozaci A, et al.
Pediatr Transplant . 2024 Nov; 28(8):e14889. PMID: 39526326
Background: Short bowel syndrome (SBS) is a malabsorptive condition that develops as a result of massive resection of the small intestine and causes morbidities such as chronic diarrhea, dehydration attacks,...
4.
Celegen K, Gulhan B, Fidan K, Yuksel S, Yilmaz N, Yilmaz A, et al.
Clin Exp Nephrol . 2024 Jul; 28(10):1038-1039. PMID: 38970651
No abstract available.
5.
Baltu D, Kurt-Sukur E, Tastemel Ozturk T, Gulhan B, Ozaltin F, Duzova A, et al.
Klin Padiatr . 2024 May; PMID: 38821068
Background: Following the pandemic of COVID-19, the main focus has been on COVID-19 vaccines and herd immunity. Although the safety of the COVID-19 vaccines has been shown in clinical trials,...
6.
Unsal Y, Baltu D, Gulhan B, Visal Okur F, Ozaltin F, Duzova A, et al.
Pediatr Transplant . 2024 May; 28(4):e14778. PMID: 38767038
Introduction: Calcineurin inhibitors (CNIs) are widely used in transplantation. Although CNI-related hyperkalemia is common (10%-60.6%), the underlying pathogenetic mechanism is not well-elucidated and may lead to dose adjustment or treatment...
7.
Kachmar J, Boyer O, Lipska-Zietkiewicz B, Moriniere V, Gribouval O, Heidet L, et al.
Kidney Int Rep . 2024 May; 9(4):973-981. PMID: 38765578
Introduction: Unlike idiopathic nephrotic syndrome (NS), hereditary podocytopathies are not expected to recur after kidney transplantation. However, some reports of posttransplant recurrence of NS in patients carrying variants in the...
8.
Celegen K, Gulhan B, Fidan K, Yuksel S, Yilmaz N, Yilmaz A, et al.
Clin Exp Nephrol . 2024 May; 28(10):1027-1037. PMID: 38704765
Background: Atypical hemolytic uremic syndrome (aHUS) is a rare, mostly complement-mediated thrombotic microangiopathy. The majority of patients are infants. In contrast to infantile-onset aHUS, the clinical and genetic characteristics of...
9.
Gulhan B, Ekici O, Dursun I, Goknar N, Yuksel S, Alaygut D, et al.
Clin Nephrol . 2024 May; 102(2):79-88. PMID: 38699986
Aims: Hepatocyte nuclear factor 1β () mutations are the most common monogenic cause of congenital anomalies of the kidney and urinary tract (CAKUT). We aimed to investigate clinical and genetic...
10.
Gulhan B, Ozaltin F, Fidan K, Ozcakar Z, Soylemezoglu O
Turk J Pediatr . 2024 Mar; 66(1):1-16. PMID: 38523374
Classical clinical triad of hemolytic uremic syndrome (HUS) is microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury associated with endothelial cell injury. Several situations, including infections, medications, malignancies, and transplantation...